ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
110 hedge funds and large institutions have $326M invested in Achillion Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
-11
Holders Change %
-9.09%
% of All Funds
2.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
38
Reduced
33
Closed
22
Calls
$399K
Puts
$75K
Net Calls
+$324K
Net Calls Change
-$674K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.82M |
| 2 |
Millennium Management
New York
|
+$9.07M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.02M |
| 4 |
MCO
MAK Capital One
New York
|
+$5.14M |
| 5 |
Goldman Sachs
New York
|
+$5.13M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$7.07M |
| 2 |
AC
Armistice Capital
New York
|
-$5.33M |
| 3 |
Two Sigma Investments
New York
|
-$2.42M |
| 4 |
Man Group
London,
United Kingdom
|
-$2.25M |
| 5 |
BlackRock
New York
|
-$1.89M |
